Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunogenicity of GlaxoSmithKline Biologicals' MMRV Vaccine (208136) vs. ProQuad®, When Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children 12-14 Months of Age.
Brief Summary: The purpose of this observer blinded study is to provide information on vaccine immunogenicity and reactogenicity in comparison with the US standard of care (ProQuad®) when administered with Hepatitis A vaccine and Pneumococcal vaccine.


Options:
A: Arm Label: GSK1437173A 18-30 Years Old Group; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling for assay of persistence of immunogenicity | Arm Label: GSK1437173A 50-70 Years Old Group; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling for assay of persistence of immunogenicity | Intervention Type: PROCEDURE; Name: Blood sampling for assay of persistence of immunogenicity; Assigned to Arm(s): GSK1437173A 18-30 Years Old Group, GSK1437173A 50-70 Years Old Group
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136), Biological: Havrix®, Biological: Prevnar® | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136), Biological: Havrix®, Biological: Prevnar® | Arm Label: Group C; Type: ACTIVE_COMPARATOR; Interventions: Biological: ProQuad®, Biological: Havrix®, Biological: Prevnar® | Intervention Type: BIOLOGICAL; Name: Priorix-Tetra™ (MMRV vaccine 208136); Assigned to Arm(s): Group A, Group B | Intervention Type: BIOLOGICAL; Name: ProQuad®; Assigned to Arm(s): Group C | Intervention Type: BIOLOGICAL; Name: Havrix®; Assigned to Arm(s): Group A, Group B, Group C | Intervention Type: BIOLOGICAL; Name: Prevnar®; Assigned to Arm(s): Group A, Group B, Group C
C: Arm Label: GSK1437173A _LD Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK1437173A Low Dose | Arm Label: GSK1437173A _MD Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK1437173A Medium Dose | Arm Label: GSK1437173A _HD Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine GSK1437173A High Dose | Arm Label: Placebo + GSK1437173A _HD Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Herpes Zoster vaccine GSK1437173A High Dose, Biological: Placebo | Arm Label: GSK1437173A_MODIFIED GROUP; Type: ACTIVE_COMPARATOR; Interventions: Biological: Herpes Zoster vaccine GSK1437173A Modified | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A Low Dose; Assigned to Arm(s): GSK1437173A _LD Group | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A Medium Dose; Assigned to Arm(s): GSK1437173A _MD Group | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A High Dose; Assigned to Arm(s): GSK1437173A _HD Group, Placebo + GSK1437173A _HD Group | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine GSK1437173A Modified; Assigned to Arm(s): GSK1437173A_MODIFIED GROUP | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo + GSK1437173A _HD Group
D: Arm Label: Priorix-Tetra new WS Group; Type: EXPERIMENTAL; Interventions: Biological: GSK Biologicals' 208136, new formulation | Arm Label: Priorix-Tetra current WS Group; Type: EXPERIMENTAL; Interventions: Biological: Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine) | Intervention Type: BIOLOGICAL; Name: Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine); Assigned to Arm(s): Priorix-Tetra current WS Group | Intervention Type: BIOLOGICAL; Name: GSK Biologicals' 208136, new formulation; Assigned to Arm(s): Priorix-Tetra new WS Group

Answer: B